This review demonstrates recent work focused on understanding the role of NFTs and monomeric/oligomeric Tau in the prion-like spreading of Tau pathology in the human brain, and does so with the aim of coming up with novel treatment paradigms for this debilitating and early onset AD form that occurs in those with DS. The gene discussed is MAPT; the disease is Dravet syndrome.